Document is current
Any future updates will be listed below
-
Authors
Monberg, Maria E. https://orcid.org/0000-0002-5643-0232
Geiger, Heather
Lee, Jaewon J. https://orcid.org/0000-0002-5677-2398
Sharma, Roshan
Semaan, Alexander https://orcid.org/0000-0001-5424-3217
Bernard, Vincent
Wong, Justin https://orcid.org/0000-0002-6803-1060
Wang, Fang
Liang, Shaoheng https://orcid.org/0000-0002-9575-1522
Swartzlander, Daniel B.
Stephens, Bret M.
Katz, Matthew H. G.
Chen, Ken https://orcid.org/0000-0003-4013-5279
Robine, Nicolas https://orcid.org/0000-0001-5698-8183
Guerrero, Paola A. https://orcid.org/0000-0002-7345-1246
Maitra, Anirban https://orcid.org/0000-0001-7923-9978
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (T32CA009599, U54CA096300, U54CA096297, T32CA217789, NIH U01CA196403, NIH U01CA200468, P50CA221707)
Deutsche Forschungsgemeinschaft (SE-2616/2-1)
- License Information
-
More Information
Article History
Received: 21 April 2021
Accepted: 15 June 2022
First Online: 25 June 2022
Competing interests
: A.M. receives royalties for a pancreatic cancer biomarker test from Cosmos Wisdom Biotechnology, and this financial relationship is managed and monitored by the UTMDACC Conflict of Interest Committee. A.M. is also listed as an inventor on a patent that has been licensed by Johns Hopkins University to Thrive Earlier Detection (Patent No. US20190256920A1, “Differential Identification of Pancreatic Cysts”), and is a consultant for Freenome and Tezcat Biotech. The remaining authors do not have competing interests to disclose.
